What is SPRAVATO®?
SPRAVATO® is a breakthrough treatment for major depressive disorder. It is an intranasal prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. TRD is defined as the failure of two or more oral antidepressants of adequate dose and duration to produce a response or remission.
If you’ve struggled with depression and tried two or more antidepressants in your current episode without adequate relief, talk with your current doctor or schedule an evaluation with us to see if SPRAVATO may benefit you.
Interpersonal psychiatry a certified treatment center where SPRAVATO is administered. We believe our experience with ketamine/spravato is important in obtaining the best outcomes for our patients. Your first visit will be a consultation to discuss the details with one of our providers. All patients require registration with the SPRAVATO REMS program and most likely a prior authorization from their insurance company prior to initiating treatment.
Each treatment session lasts two hours, during which patients are monitored in a comfortable setting. Due to the possible side effects of the SPRVATO treatment, you are not allowed to drive after treatment and must be picked up by a friend, family member, or ride share service.